Current genetic models for studying congenital heart diseases: Advantages and disadvantages

• Published in: Bioinformation 2024-05, Vol.20 (5), p.415-429
• Main Authors: Shorbaji, Ayat, Pushparaj, Peter Natesan, Bakhashab, Sherin, Al-Ghafari, Ayat B, Al-Rasheed, Rana R, Siraj Mira, Loubna, Basabrain, Mohammad Abdullah, Alsulami, Majed, Abu Zeid, Isam M, Naseer, Muhammad Imran, Rasool, Mahmood
• Format: Article
• Language: English
• Subjects: Amphibians; Animal models; Blood vessels; Cardiovascular diseases; Cell culture; Congenital diseases; Coronary artery disease; CRISPR; Cross-reactivity; Disease; Drosophila; Embryo cells; Embryogenesis; Epidemiology; Frogs; Fruit flies; Gene duplication; Genes; Genetic factors; Genetic modification; Heart; Heart diseases; In vivo methods and tests; Insects; Juveniles; Molecular modelling; Physiology; Pluripotency; Primates; Rabbits; Stem cells; Structure-function relationships; Xenopus; Zebrafish
• ISSN: 0973-2063; 0973-8894; 0973-2063
• DOI: 10.6026/973206300200415

Congenital heart disease (CHD) encompasses a diverse range of structural and functional anomalies that affect the heart and the major blood vessels. Epidemiological studies have documented a global increase in CHD prevalence, which can be attributed to advancements in diagnostic technologies. Extensive research has identified a plethora of CHD-related genes, providing insights into the biochemical pathways and molecular mechanisms underlying this pathological state. In this review, we discuss the advantages and challenges of various and CHD models, including primates, canines, Xenopus frogs, rabbits, chicks, mice, Drosophila, zebrafish, and induced pluripotent stem cells (iPSCs). Primates are closely related to humans but are rare and expensive. Canine models are costly but structurally comparable to humans. Xenopus frogs are advantageous because of their generation of many embryos, ease of genetic modification, and cardiac similarity. Rabbits mimic human physiology but are challenging to genetically control. Chicks are inexpensive and simple to handle; however, cardiac events can vary among humans. Mice differ physiologically, while being evolutionarily close and well-resourced. Drosophila has genes similar to those of humans but different heart structures. Zebrafish have several advantages, including high gene conservation in humans and physiological cardiac similarities but limitations in cross-reactivity with mammalian antibodies, gene duplication, and limited embryonic stem cells for reverse genetic methods. iPSCs have the potential for gene editing, but face challenges in terms of 2D structure and genomic stability. CRISPR-Cas9 allows for genetic correction but requires high technical skills and resources. These models have provided valuable knowledge regarding cardiac development, disease simulation, and the verification of genetic factors. This review highlights the distinct features of various models with respect to their biological characteristics, vulnerability to developing specific heart diseases, approaches employed to induce particular conditions, and the comparability of these species to humans. Therefore, the selection of appropriate models is based on research objectives, ultimately leading to an enhanced comprehension of disease pathology and therapy.